Official SEC submissions
BriaCell Therapeutics SEC Filings
BriaCell Therapeutics (BCTX) SEC filings, periodic reports and insider submissi…
Direct answer
BriaCell Therapeutics's latest SEC filing is 8-K.
Get free BriaCell Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Recent SEC filings
8-K
Current report
Filed:
Report date:
S-1/A
Registration statement
Filed:
S-1
Registration statement
Filed:
10-Q
Periodic report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
DEFA14A
Proxy statement
Filed:
DEF 14A
Proxy statement
Filed:
Report date:
10-Q
Periodic report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
8-K
Current report
Filed:
Report date:
SC 13D/A
Ownership report
Filed:
SC 13D/A
Ownership report
Filed:
SC 13D/A
Ownership report
Filed:
Verified data
- Recent filing categories
- 5
- Recent filings
- 40
- SEC CIK
- 0001610820
- Latest filing date
- June 26, 2026